v3.25.2
Significant Accounting Policies (Details)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2025
USD ($)
investment
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
investment
Jun. 30, 2024
USD ($)
Sep. 30, 2024
USD ($)
investment
Restricted Cash and Cash Equivalent Item [Line Items]          
Restricted cash $ 48,070   $ 48,070   $ 43,328
Amortization period (in months) 12 months   12 months    
Organization expenses $ 3 $ 4 $ 5 $ 8  
Deferred offering costs 1,201   1,201   554
Amortization of deferred financing costs 589 $ 261 1,508 $ 694  
SPV credit facilities | Line of Credit          
Restricted Cash and Cash Equivalent Item [Line Items]          
Restricted cash $ 48,100   $ 48,100   $ 43,300
Investment Owned, Fair Value | Investment Type Concentration Risk | Non-Accrual Status, Debt Securities          
Restricted Cash and Cash Equivalent Item [Line Items]          
Number of investments | investment 1   1   1
Concentration risk (as a percent)     0.10%   0.10%
Investment Owned, Cost | Investment Type Concentration Risk | Non-Accrual Status, Debt Securities          
Restricted Cash and Cash Equivalent Item [Line Items]          
Concentration risk (as a percent)     0.20%   0.10%